British Columbia Investment Management Corp Biomarin Pharmaceutical Inc Transaction History

British Columbia Investment Management Corp

  • $16 Billion
  • Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 31,676 shares of BMRN stock, worth $2.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,676
Previous 36,343 12.84%
Holding current value
$2.11 Million
Previous $2.99 Million 25.6%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $322,116 - $437,951
-4,667 Reduced 12.84%
31,676 $2.23 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $1.03 Million - $1.28 Million
13,853 Added 61.6%
36,343 $2.99 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $68,556 - $80,982
818 Added 3.77%
22,490 $1.96 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $350,688 - $453,244
4,601 Added 26.95%
21,672 $2.09 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $13,526 - $15,022
159 Added 0.94%
17,071 $1.51 Million
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $41,866 - $48,444
483 Added 2.94%
16,912 $1.47 Million
Q4 2022

Feb 10, 2023
SELL
$80.93 - $108.63 $151,824 - $203,789
-1,876 Reduced 10.25%
16,429 $1.7 Million
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $239,907 - $283,064
-2,920 Reduced 13.76%
18,305 $1.55 Million
Q2 2022

Aug 12, 2022
SELL
$71.48 - $86.85 $508,794 - $618,198
-7,118 Reduced 25.11%
21,225 $1.76 Million
Q1 2022

May 12, 2022
SELL
$74.28 - $92.69 $285,012 - $355,651
-3,837 Reduced 11.92%
28,343 $2.19 Million
Q4 2021

Feb 11, 2022
SELL
$71.72 - $91.47 $115,899 - $147,815
-1,616 Reduced 4.78%
32,180 $2.84 Million
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $14,056 - $16,068
188 Added 0.56%
33,796 $2.61 Million
Q2 2021

Aug 09, 2021
BUY
$75.51 - $84.79 $291,468 - $327,289
3,860 Added 12.98%
33,608 $2.8 Million
Q1 2021

Apr 30, 2021
SELL
$74.73 - $90.69 $62,025 - $75,272
-830 Reduced 2.71%
29,748 $2.25 Million
Q4 2020

Feb 02, 2021
SELL
$72.61 - $90.2 $56,998 - $70,807
-785 Reduced 2.5%
30,578 $2.68 Million
Q3 2020

Nov 10, 2020
BUY
$71.87 - $131.03 $182,909 - $333,471
2,545 Added 8.83%
31,363 $2.39 Million
Q2 2020

Aug 12, 2020
BUY
$79.55 - $124.22 $729,473 - $1.14 Million
9,170 Added 46.67%
28,818 $3.55 Million
Q1 2020

May 13, 2020
SELL
$71.37 - $96.85 $1.62 Million - $2.19 Million
-22,641 Reduced 53.54%
19,648 $1.66 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $84,000 - $112,885
1,307 Added 3.19%
42,289 $3.58 Million
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $672,382 - $849,057
-9,976 Reduced 19.58%
40,982 $2.76 Million
Q2 2019

Aug 12, 2019
BUY
$80.35 - $93.9 $190,349 - $222,449
2,369 Added 4.88%
50,958 $4.37 Million
Q1 2019

May 08, 2019
SELL
$84.2 - $98.62 $976,720 - $1.14 Million
-11,600 Reduced 19.27%
48,589 $4.32 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $469,139 - $620,933
5,854 Added 10.77%
60,189 $5.13 Million
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $1.86 Million - $2.09 Million
-19,770 Reduced 26.68%
54,335 $5.27 Million
Q2 2018

Aug 09, 2018
SELL
$76.01 - $99.03 $1.53 Million - $1.99 Million
-20,071 Reduced 21.31%
74,105 $6.98 Million
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $1.82 Million - $2.17 Million
-23,408 Reduced 19.91%
94,176 $7.64 Million
Q4 2017

Feb 20, 2018
BUY
$80.76 - $95.13 $607,072 - $715,092
7,517 Added 6.83%
117,584 $10.5 Million
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $8.87 Million - $10.5 Million
110,067
110,067 $10.2 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email